Short Information | Forward Pharma A/S (NASDAQ:FWP)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 33,331 |
Total Actual Volume | 385,610 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 1 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,667 |
Average Short Percentage | 12.83% |
Is there a FWP Short Squeeze or Breakout about to happen?
See the FWP Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
12-27-2022 | $1.94 | $1.95 | $2.06 | $1.94 | 29,656 | 3,122 | 10.53% |
12-23-2022 | $1.95 | $1.81 | $2.075 | $1.81 | 49,649 | 3,015 | 6.07% |
12-22-2022 | $1.83 | $1.96 | $1.98 | $1.83 | 3,476 | 15 | 0.43% |
12-21-2022 | $1.811 | $1.8 | $2 | $1.79 | 45,038 | 4,717 | 10.47% |
12-20-2022 | $1.75 | $1.81 | $1.89 | $1.7 | 127,057 | 10,807 | 8.51% |
12-19-2022 | $2.35 | $1.79 | $2.35 | $1.5 | 101,512 | 6,999 | 6.89% |
12-14-2022 | $2.93 | $2.72 | $2.93 | $2.72 | 1,460 | 400 | 27.4% |
12-13-2022 | $2.96 | $3 | $3 | $2.96 | 442 | 100 | 22.62% |
12-12-2022 | $2.7 | $2.97 | $3 | $2.7 | 3,314 | 250 | 7.54% |
12-07-2022 | $2.9719 | $2.92 | $2.9719 | $2.72 | 2,170 | 1,116 | 51.43% |
12-06-2022 | $2.8 | $3.19 | $3.19 | $2.4 | 3,856 | 1,011 | 26.22% |
12-05-2022 | $0 | $2.81 | $0 | $0 | 166 | 8 | 4.82% |
12-01-2022 | $2.8 | $2.945 | $3.02 | $2.8 | 4,405 | 1,286 | 29.19% |
11-30-2022 | $2.9538 | $2.97 | $3.075 | $2.8 | 1,753 | 50 | 2.85% |
11-29-2022 | $2.8 | $2.92 | $2.95 | $2.8 | 791 | 200 | 25.28% |
11-25-2022 | $2.9 | $3 | $3 | $2.7 | 4,009 | 104 | 2.59% |
11-21-2022 | $3.07 | $3.07 | $3.09 | $3 | 875 | 100 | 11.43% |
11-17-2022 | $3.01 | $2.95 | $3.01 | $2.94 | 699 | 6 | 0.86% |
11-15-2022 | $2.95 | $2.92 | $2.96 | $2.9 | 1,552 | 23 | 1.48% |
11-14-2022 | $3.2 | $2.95 | $3.2 | $2.92 | 3,730 | 2 | 0.05% |
News, Short Squeeze, Breakout and More Instantly...
COPENHAGEN, Denmark, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward”), today announced that that on December 16, 2022 it received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) notifying us that Nasdaq beli...
COPENHAGEN, Denmark, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”), today announced that the Enlarged Board of Appeal (the “EBA”) of the European Patent Office (the “EPO”) has denied Forward...
COPENHAGEN, Denmark, April 08, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported consolidated financial results for the year end...